欲速则不达：尚无确凿证据可将干细胞疗法应用于自闭症谱系障碍儿童的临床实践。
Haste Makes Waste: There Is No Solid Evidence to Translate the Use of Stem Cells into Clinical Practice for Children with Autism Spectrum Disorder.
作者信息
Narzisi Antonio
机构信息
IRCCS Stella Maris Foundation, 56018 Pisa, Italy.
出版信息
Brain Sci. 2022 Jul 27;12(8):992. doi: 10.3390/brainsci12080992.
Abstract
Increasingly, private clinics around the world offer stem cell therapy as a therapeutic approach for autism spectrum disorder (ASD) [...].
摘要
世界各地越来越多的私人诊所提供干细胞疗法，作为治疗自闭症谱系障碍（ASD）的一种治疗方法[……]。
相似文献
1
Haste Makes Waste: There Is No Solid Evidence to Translate the Use of Stem Cells into Clinical Practice for Children with Autism Spectrum Disorder.欲速则不达：尚无确凿证据可将干细胞疗法应用于自闭症谱系障碍儿童的临床实践。
Brain Sci. 2022 Jul 27;12(8):992. doi: 10.3390/brainsci12080992.
2
The use of stem cells to study autism spectrum disorder.利用干细胞研究自闭症谱系障碍。
Yale J Biol Med. 2015 Mar 4;88(1):5-16. eCollection 2015 Mar.
3
Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.8 岁儿童自闭症谱系障碍患病率 - 自闭症及发育障碍监测网，美国 11 个监测点，2014 年。
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23. doi: 10.15585/mmwr.ss6706a1.
4
Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells.mTOR 信号的失调介导了特发性和 16p11.2 缺失自闭症神经前体细胞中常见的神经突和迁移缺陷。
Elife. 2024 Mar 25;13:e82809. doi: 10.7554/eLife.82809.
5
Clustering of co-occurring conditions in autism spectrum disorder during early childhood: A retrospective analysis of medical claims data.自闭症谱系障碍幼儿期共病情况聚类：医疗索赔数据分析的回顾性分析。
Autism Res. 2019 Aug;12(8):1272-1285. doi: 10.1002/aur.2128. Epub 2019 May 31.
6
Selected Methods of Therapeutic Interactions With People With Mild Symptoms of Autism Spectrum Disorder.与自闭症谱系障碍轻度症状患者进行治疗互动的选定方法。
Front Psychiatry. 2022 Jul 15;13:942218. doi: 10.3389/fpsyt.2022.942218. eCollection 2022.
7
Prevalence of Autism Spectrum Disorder in Children Referred for Diagnostic Autism Evaluation.因自闭症诊断评估而接受转诊的儿童中自闭症谱系障碍的患病率。
Clin Pediatr (Phila). 2015 Dec;54(14):1322-7. doi: 10.1177/0009922815592607. Epub 2015 Jun 29.
8
An Open-Label Case Series of Glutathione Use for Symptomatic Management in Children with Autism Spectrum Disorder.谷胱甘肽治疗自闭症谱系障碍儿童症状管理的开放性病例系列研究。
Med Sci (Basel). 2023 Nov 15;11(4):73. doi: 10.3390/medsci11040073.
9
Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5.注意力缺陷/多动障碍（ADHD）儿童中家长报告及临床医生观察到的自闭症谱系障碍（ASD）症状：对《精神疾病诊断与统计手册》第5版下实践的启示
Mol Autism. 2016 Jan 19;7:7. doi: 10.1186/s13229-016-0072-1. eCollection 2016.
10
Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy.自闭症谱系障碍儿童的粪便和血浆代谢物特征及其菌群移植治疗后的变化。
mSphere. 2020 Oct 21;5(5):e00314-20. doi: 10.1128/mSphere.00314-20.
引用本文的文献
1
Autologous cord blood individualized supplements in autistic spectrum disorder: CORDUS study results.自闭症谱系障碍中的自体脐带血个体化补充剂：CORDUS研究结果。
World J Clin Pediatr. 2025 Mar 9;14(1):96643. doi: 10.5409/wjcp.v14.i1.96643.
2
Tempering expectations: considerations on the current state of stem cells therapy for autism treatment.调整期望：关于自闭症治疗干细胞疗法现状的思考
Front Psychiatry. 2023 Oct 3;14:1287879. doi: 10.3389/fpsyt.2023.1287879. eCollection 2023.
本文引用的文献
1
Efficacy and Safety of Stem Cell Therapy in Children With Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.干细胞疗法治疗儿童自闭症谱系障碍的疗效与安全性：一项系统评价与荟萃分析
Front Pediatr. 2022 May 4;10:897398. doi: 10.3389/fped.2022.897398. eCollection 2022.
2
Stem Cell Therapy in the Treatment of Patients With Autism Spectrum Disorder: a Systematic Review and Meta-analysis.干细胞疗法治疗自闭症谱系障碍患者：一项系统评价与荟萃分析。
Stem Cell Rev Rep. 2022 Jan;18(1):155-164. doi: 10.1007/s12015-021-10257-0. Epub 2021 Sep 13.
3
Intrathecal autologous bone marrow stem cell therapy in children with autism: A randomized controlled trial.鞘内注射自体骨髓干细胞疗法治疗儿童自闭症：一项随机对照试验。
Asia Pac Psychiatry. 2021 Jun;13(2):e12445. doi: 10.1111/appy.12445. Epub 2020 Nov 4.
4
Outcomes of bone marrow mononuclear cell transplantation combined with interventional education for autism spectrum disorder.骨髓单个核细胞移植联合介入教育治疗孤独症谱系障碍的疗效。
Stem Cells Transl Med. 2021 Jan;10(1):14-26. doi: 10.1002/sctm.20-0102. Epub 2020 Sep 9.
5
Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder.输注人脐带组织间充质干细胞治疗自闭症谱系障碍。
Stem Cells Transl Med. 2020 Oct;9(10):1137-1146. doi: 10.1002/sctm.19-0434. Epub 2020 Jun 12.
6
A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.一项评估静脉输注脐带血治疗自闭症谱系障碍儿童的安全性和有效性的 II 期随机临床试验。
J Pediatr. 2020 Jul;222:164-173.e5. doi: 10.1016/j.jpeds.2020.03.011. Epub 2020 May 19.
7
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels.异体人脐带间充质干细胞治疗儿童孤独症谱系障碍：安全性特征及对细胞因子水平的影响。
Stem Cells Transl Med. 2019 Oct;8(10):1008-1016. doi: 10.1002/sctm.19-0010. Epub 2019 Jun 11.
8
White Matter Tract Changes Associated with Clinical Improvement in an Open-Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism.在一项评估自体脐血治疗自闭症儿童的开放性试验中，与临床改善相关的白质束变化。
Stem Cells Transl Med. 2019 Feb;8(2):138-147. doi: 10.1002/sctm.18-0251. Epub 2019 Jan 8.
9
Stem cell therapy in autism: recent insights.自闭症的干细胞疗法：最新见解
Stem Cells Cloning. 2018 Oct 23;11:55-67. doi: 10.2147/SCCAA.S155410. eCollection 2018.
10
Electrophysiological Biomarkers Predict Clinical Improvement in an Open-Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism.电生理生物标志物可预测开放性试验中自体脐带血治疗自闭症疗效的临床改善。
Stem Cells Transl Med. 2018 Nov;7(11):783-791. doi: 10.1002/sctm.18-0090. Epub 2018 Aug 1.
Zotero 插件